{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:49:09Z","timestamp":1780328949014,"version":"3.54.1"},"reference-count":77,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"S\u00e3o Paulo Research Foundation-FAPESP","award":["2022\/13150-0"],"award-info":[{"award-number":["2022\/13150-0"]}]},{"name":"S\u00e3o Paulo Research Foundation-FAPESP","award":["2023\/05478-8"],"award-info":[{"award-number":["2023\/05478-8"]}]},{"name":"S\u00e3o Paulo Research Foundation-FAPESP","award":["307193\/2023-3"],"award-info":[{"award-number":["307193\/2023-3"]}]},{"name":"S\u00e3o Paulo Research Foundation-FAPESP","award":["403464\/2023-4"],"award-info":[{"award-number":["403464\/2023-4"]}]},{"name":"S\u00e3o Paulo Research Foundation-FAPESP","award":["304033\/2021-9"],"award-info":[{"award-number":["304033\/2021-9"]}]},{"name":"S\u00e3o Paulo Research Foundation-FAPESP","award":["AI001150"],"award-info":[{"award-number":["AI001150"]}]},{"name":"S\u00e3o Paulo Research Foundation-FAPESP","award":["88887.509097\/2020-00"],"award-info":[{"award-number":["88887.509097\/2020-00"]}]},{"name":"S\u00e3o Paulo Research Foundation-FAPESP","award":["88887.929469\/2023-00"],"award-info":[{"award-number":["88887.929469\/2023-00"]}]},{"name":"S\u00e3o Paulo Research Foundation-FAPESP","award":["E-26\/200.314\/2022-260923"],"award-info":[{"award-number":["E-26\/200.314\/2022-260923"]}]},{"name":"S\u00e3o Paulo Research Foundation-FAPESP","award":["VPPCB-005-FIO-20-2-49"],"award-info":[{"award-number":["VPPCB-005-FIO-20-2-49"]}]},{"name":"National Council for Scientific and Technological Development-CNPq","award":["2022\/13150-0"],"award-info":[{"award-number":["2022\/13150-0"]}]},{"name":"National Council for Scientific and Technological Development-CNPq","award":["2023\/05478-8"],"award-info":[{"award-number":["2023\/05478-8"]}]},{"name":"National Council for Scientific and Technological Development-CNPq","award":["307193\/2023-3"],"award-info":[{"award-number":["307193\/2023-3"]}]},{"name":"National Council for Scientific and Technological Development-CNPq","award":["403464\/2023-4"],"award-info":[{"award-number":["403464\/2023-4"]}]},{"name":"National Council for Scientific and Technological Development-CNPq","award":["304033\/2021-9"],"award-info":[{"award-number":["304033\/2021-9"]}]},{"name":"National Council for Scientific and Technological Development-CNPq","award":["AI001150"],"award-info":[{"award-number":["AI001150"]}]},{"name":"National Council for Scientific and Technological Development-CNPq","award":["88887.509097\/2020-00"],"award-info":[{"award-number":["88887.509097\/2020-00"]}]},{"name":"National Council for Scientific and Technological Development-CNPq","award":["88887.929469\/2023-00"],"award-info":[{"award-number":["88887.929469\/2023-00"]}]},{"name":"National Council for Scientific and Technological Development-CNPq","award":["E-26\/200.314\/2022-260923"],"award-info":[{"award-number":["E-26\/200.314\/2022-260923"]}]},{"name":"National Council for Scientific and Technological Development-CNPq","award":["VPPCB-005-FIO-20-2-49"],"award-info":[{"award-number":["VPPCB-005-FIO-20-2-49"]}]},{"name":"Division of Intramural Research of NIAID\/NIH","award":["2022\/13150-0"],"award-info":[{"award-number":["2022\/13150-0"]}]},{"name":"Division of Intramural Research of NIAID\/NIH","award":["2023\/05478-8"],"award-info":[{"award-number":["2023\/05478-8"]}]},{"name":"Division of Intramural Research of NIAID\/NIH","award":["307193\/2023-3"],"award-info":[{"award-number":["307193\/2023-3"]}]},{"name":"Division of Intramural Research of NIAID\/NIH","award":["403464\/2023-4"],"award-info":[{"award-number":["403464\/2023-4"]}]},{"name":"Division of Intramural Research of NIAID\/NIH","award":["304033\/2021-9"],"award-info":[{"award-number":["304033\/2021-9"]}]},{"name":"Division of Intramural Research of NIAID\/NIH","award":["AI001150"],"award-info":[{"award-number":["AI001150"]}]},{"name":"Division of Intramural Research of NIAID\/NIH","award":["88887.509097\/2020-00"],"award-info":[{"award-number":["88887.509097\/2020-00"]}]},{"name":"Division of Intramural Research of NIAID\/NIH","award":["88887.929469\/2023-00"],"award-info":[{"award-number":["88887.929469\/2023-00"]}]},{"name":"Division of Intramural Research of NIAID\/NIH","award":["E-26\/200.314\/2022-260923"],"award-info":[{"award-number":["E-26\/200.314\/2022-260923"]}]},{"name":"Division of Intramural Research of NIAID\/NIH","award":["VPPCB-005-FIO-20-2-49"],"award-info":[{"award-number":["VPPCB-005-FIO-20-2-49"]}]},{"name":"Coordination for the Improvement of Higher Education Personnel-CAPES","award":["2022\/13150-0"],"award-info":[{"award-number":["2022\/13150-0"]}]},{"name":"Coordination for the Improvement of Higher Education Personnel-CAPES","award":["2023\/05478-8"],"award-info":[{"award-number":["2023\/05478-8"]}]},{"name":"Coordination for the Improvement of Higher Education Personnel-CAPES","award":["307193\/2023-3"],"award-info":[{"award-number":["307193\/2023-3"]}]},{"name":"Coordination for the Improvement of Higher Education Personnel-CAPES","award":["403464\/2023-4"],"award-info":[{"award-number":["403464\/2023-4"]}]},{"name":"Coordination for the Improvement of Higher Education Personnel-CAPES","award":["304033\/2021-9"],"award-info":[{"award-number":["304033\/2021-9"]}]},{"name":"Coordination for the Improvement of Higher Education Personnel-CAPES","award":["AI001150"],"award-info":[{"award-number":["AI001150"]}]},{"name":"Coordination for the Improvement of Higher Education Personnel-CAPES","award":["88887.509097\/2020-00"],"award-info":[{"award-number":["88887.509097\/2020-00"]}]},{"name":"Coordination for the Improvement of Higher Education Personnel-CAPES","award":["88887.929469\/2023-00"],"award-info":[{"award-number":["88887.929469\/2023-00"]}]},{"name":"Coordination for the Improvement of Higher Education Personnel-CAPES","award":["E-26\/200.314\/2022-260923"],"award-info":[{"award-number":["E-26\/200.314\/2022-260923"]}]},{"name":"Coordination for the Improvement of Higher Education Personnel-CAPES","award":["VPPCB-005-FIO-20-2-49"],"award-info":[{"award-number":["VPPCB-005-FIO-20-2-49"]}]},{"name":"Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro-FAPERJ","award":["2022\/13150-0"],"award-info":[{"award-number":["2022\/13150-0"]}]},{"name":"Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro-FAPERJ","award":["2023\/05478-8"],"award-info":[{"award-number":["2023\/05478-8"]}]},{"name":"Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro-FAPERJ","award":["307193\/2023-3"],"award-info":[{"award-number":["307193\/2023-3"]}]},{"name":"Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro-FAPERJ","award":["403464\/2023-4"],"award-info":[{"award-number":["403464\/2023-4"]}]},{"name":"Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro-FAPERJ","award":["304033\/2021-9"],"award-info":[{"award-number":["304033\/2021-9"]}]},{"name":"Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro-FAPERJ","award":["AI001150"],"award-info":[{"award-number":["AI001150"]}]},{"name":"Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro-FAPERJ","award":["88887.509097\/2020-00"],"award-info":[{"award-number":["88887.509097\/2020-00"]}]},{"name":"Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro-FAPERJ","award":["88887.929469\/2023-00"],"award-info":[{"award-number":["88887.929469\/2023-00"]}]},{"name":"Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro-FAPERJ","award":["E-26\/200.314\/2022-260923"],"award-info":[{"award-number":["E-26\/200.314\/2022-260923"]}]},{"name":"Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro-FAPERJ","award":["VPPCB-005-FIO-20-2-49"],"award-info":[{"award-number":["VPPCB-005-FIO-20-2-49"]}]},{"DOI":"10.13039\/501100006507","name":"Oswaldo Cruz Foundation Rio de Janeiro-FIOCRUZ","doi-asserted-by":"publisher","award":["2022\/13150-0"],"award-info":[{"award-number":["2022\/13150-0"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Oswaldo Cruz Foundation Rio de Janeiro-FIOCRUZ","doi-asserted-by":"publisher","award":["2023\/05478-8"],"award-info":[{"award-number":["2023\/05478-8"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Oswaldo Cruz Foundation Rio de Janeiro-FIOCRUZ","doi-asserted-by":"publisher","award":["307193\/2023-3"],"award-info":[{"award-number":["307193\/2023-3"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Oswaldo Cruz Foundation Rio de Janeiro-FIOCRUZ","doi-asserted-by":"publisher","award":["403464\/2023-4"],"award-info":[{"award-number":["403464\/2023-4"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Oswaldo Cruz Foundation Rio de Janeiro-FIOCRUZ","doi-asserted-by":"publisher","award":["304033\/2021-9"],"award-info":[{"award-number":["304033\/2021-9"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Oswaldo Cruz Foundation Rio de Janeiro-FIOCRUZ","doi-asserted-by":"publisher","award":["AI001150"],"award-info":[{"award-number":["AI001150"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Oswaldo Cruz Foundation Rio de Janeiro-FIOCRUZ","doi-asserted-by":"publisher","award":["88887.509097\/2020-00"],"award-info":[{"award-number":["88887.509097\/2020-00"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Oswaldo Cruz Foundation Rio de Janeiro-FIOCRUZ","doi-asserted-by":"publisher","award":["88887.929469\/2023-00"],"award-info":[{"award-number":["88887.929469\/2023-00"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Oswaldo Cruz Foundation Rio de Janeiro-FIOCRUZ","doi-asserted-by":"publisher","award":["E-26\/200.314\/2022-260923"],"award-info":[{"award-number":["E-26\/200.314\/2022-260923"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Oswaldo Cruz Foundation Rio de Janeiro-FIOCRUZ","doi-asserted-by":"publisher","award":["VPPCB-005-FIO-20-2-49"],"award-info":[{"award-number":["VPPCB-005-FIO-20-2-49"]}],"id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The regulation of angiotensin-converting enzyme 2 (ACE2) expression by medications such as ACE inhibitors (ACEis) and angiotensin receptor blockers (ARBs) has raised critical questions regarding their potential benefits and risks during COVID-19. ACE2, a regulator of blood pressure through the renin\u2013angiotensin system (RAS), is the primary receptor for SARS-CoV-2. ACEis and ARBs can modulate ACE2 expression, potentially exacerbating viral load. However, the risks of higher viral load could be mitigated by favorable anti-inflammatory responses associated with ACEi and ARB use, highlighting the complexity of their impact on viral replication and disease outcomes. This study investigates the effects of sustained Losartan monotherapy (ARB) and combination Losartan + Lisinopril (ARB + ACEi) on viral replication, inflammation, lung function, and clinical measures of disease severity in a murine model of severe COVID-19 involving humanized ACE2 transgenic mice infected with SARS-CoV-2 Wuhan strain. Both ARB and ARB + ACEi treatments led to increased ACE2 expression in the lungs and higher viral load post-infection. Despite this, the ARB + ACEi combination improved clinical scores, reduced weight loss and inflammatory cytokine levels, and preserved lung function, though it did not improve survival. Overall, the results of these controlled experiments provide insight into the complex dynamics of ACEi and ARB use in COVID-19; while these drugs induce expression of the ACE2 receptor and increase viral load, they provide compensatory modulation of the inflammatory response that appears to diminish severity of the infection.<\/jats:p>","DOI":"10.3390\/ijms26167663","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T09:56:42Z","timestamp":1754647002000},"page":"7663","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Angiotensin-Converting Enzyme Inhibition and\/or Angiotensin Receptor Blockade Modulate Cytokine Profiles and Improve Clinical Outcomes in Experimental COVID-19 Infection"],"prefix":"10.3390","volume":"26","author":[{"given":"Yasmin","family":"da Silva-Santos","sequence":"first","affiliation":[{"name":"Laboratory of Cellular and Molecular Immunopathology of Malaria, Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of S\u00e3o Paulo, S\u00e3o Paulo 05508-000, Brazil"},{"name":"Laboratory of Malaria Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Liberato","family":"Pagni","sequence":"additional","affiliation":[{"name":"Immunology Laboratory, Heart Institute, Faculty of Medicine, University of S\u00e3o Paulo, S\u00e3o Paulo 05403-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais Helena Martins","family":"Gamon","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Molecular Virology, Institute of Biomedical Sciences, Department of Microbiology, University of S\u00e3o Paulo, S\u00e3o Paulo 05508-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5694-4578","authenticated-orcid":false,"given":"Marcela Santiago Pacheco","family":"de Azevedo","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Molecular Virology, Institute of Biomedical Sciences, Department of Microbiology, University of S\u00e3o Paulo, S\u00e3o Paulo 05508-000, Brazil"},{"name":"Laboratory of Experimental Immunoparasitology, Institute of Biomedical Sciences, Department of Parasitology, University of S\u00e3o Paulo, S\u00e3o Paulo 05508-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2042-6776","authenticated-orcid":false,"given":"Maria Laura Goussain","family":"Darido","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Molecular Virology, Institute of Biomedical Sciences, Department of Microbiology, University of S\u00e3o Paulo, S\u00e3o Paulo 05508-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Bruna Leal","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Molecular Virology, Institute of Biomedical Sciences, Department of Microbiology, University of S\u00e3o Paulo, S\u00e3o Paulo 05508-000, Brazil"},{"name":"Hospital Israelita Albert Einstein, S\u00e3o Paulo 05652-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4898-6553","authenticated-orcid":false,"given":"Edson Luiz","family":"Durigon","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Molecular Virology, Institute of Biomedical Sciences, Department of Microbiology, University of S\u00e3o Paulo, S\u00e3o Paulo 05508-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cec\u00edlia Rui","family":"Luvizotto","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine of Ara\u00e7atuba, S\u00e3o Paulo State University, S\u00e3o Paulo 16050-680, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4940-3305","authenticated-orcid":false,"given":"Hans Christian","family":"Ackerman","sequence":"additional","affiliation":[{"name":"Physiology Unit, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Rockville, MD 20852, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1227-3845","authenticated-orcid":false,"given":"Claudio Romero Farias","family":"Marinho","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Immunoparasitology, Institute of Biomedical Sciences, Department of Parasitology, University of S\u00e3o Paulo, S\u00e3o Paulo 05508-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0133-6430","authenticated-orcid":false,"given":"Leonardo Jos\u00e9 de Moura","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Laboratory of Malaria Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6094-9750","authenticated-orcid":false,"given":"Sabrina","family":"Epiphanio","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Immunopathology of Malaria, Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of S\u00e3o Paulo, S\u00e3o Paulo 05508-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"ref_1","unstructured":"(2024, December 20). KFF Global COVID-19 Tracker. Available online: https:\/\/www.kff.org\/coronavirus-covid-19\/issue-brief\/global-covid-19-tracker\/."},{"key":"ref_2","unstructured":"World Health Organization (2024, December 20). COVID-19 Epidemiological Update, Edition 169, 15 July 2024. Available online: https:\/\/www.who.int\/publications\/m\/item\/covid-19-epidemiological-update-edition-169\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","article-title":"Long COVID Science, Research and Policy","volume":"30","author":"Davis","year":"2024","journal-title":"Nat. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Chaudhry, F., Lavandero, S., Xie, X., Sabharwal, B., Zheng, Y.Y., Correa, A., Narula, J., and Levy, P. (2020). Manipulation of ACE2 Expression in COVID-19. Open Hear., 7.","DOI":"10.1136\/openhrt-2020-001424"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/HYPERTENSIONAHA.123.21364","article-title":"Alternative Renin-Angiotensin System","volume":"81","author":"Bader","year":"2024","journal-title":"Hypertension"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/med.21996","article-title":"Diverse Biological Functions of the Renin-angiotensin System","volume":"44","author":"Rao","year":"2024","journal-title":"Med. Res. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hrenak, J., and Simko, F. (2020). Renin\u2013Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218038"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2008.01981.x","article-title":"Renin-angiotensin System Revisited","volume":"264","author":"Fyhrquist","year":"2008","journal-title":"J. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chen, H., Peng, J., Wang, T., Wen, J., Chen, S., Huang, Y., and Zhang, Y. (2023). Counter-Regulatory Renin-Angiotensin System in Hypertension: Review and Update in the Era of COVID-19 Pandemic. Biochem. Pharmacol., 208.","DOI":"10.1016\/j.bcp.2022.115370"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Brooks, S.D., Smith, R.L., Moreira, A.S., and Ackerman, H.C. (2022). Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.798349"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e016509","DOI":"10.1161\/JAHA.120.016509","article-title":"Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors\/ Angiotensin Receptor Blockers Have a Biphasic Effect?","volume":"9","author":"Sommerstein","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_14","first-page":"1769","article-title":"COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers What Is the Evidence ?","volume":"323","author":"Patel","year":"2020","journal-title":"JAMA"},{"key":"ref_15","first-page":"469","article-title":"Risk Factors for COVID-19","volume":"28","author":"Rashedi","year":"2020","journal-title":"Le. Infez. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2217\/pgs-2020-0048","article-title":"ACE2 and COVID-19: Using Antihypertensive Medications and Pharmacogenetic Considerations","volume":"21","author":"Snyder","year":"2020","journal-title":"Pharmacogenomics"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ddmec.2006.06.012","article-title":"The Renin\u2013Angiotensin System in Acute Respiratory Distress Syndrome","volume":"3","author":"Imai","year":"2006","journal-title":"Drug Discov. Today Dis. Mech."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.2174\/0929867324666170414162841","article-title":"Circulating ACE2 in Cardiovascular and Kidney Diseases","volume":"24","author":"Anguiano","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.HYP.31.2.699","article-title":"Vasodepressor Actions of Angiotensin-(1\u20137) Unmasked During Combined Treatment with Lisinopril and Losartan","volume":"31","author":"Iyer","year":"1998","journal-title":"Hypertension"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00041552-200207000-00001","article-title":"Combination ACEI and ARB Therapy: Additional Benefit in Renoprotection?","volume":"11","author":"Taal","year":"2002","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0066-782X2000000200001","article-title":"Reduction in Left Ventricular Hypertrophy in Hypertensive Patients Treated with Enalapril, Losartan or the Combination of Enalapril and Losartan","volume":"74","author":"Mill","year":"2000","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2022.04.001","article-title":"Discontinuing vs Continuing ACEIs and ARBs in Hospitalized Patients with COVID-19 According to Disease Severity: Insights from the BRACE CORONA Trial","volume":"249","author":"Macedo","year":"2022","journal-title":"Am. Heart J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted with COVID-19","volume":"325","author":"Lopes","year":"2021","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-Angiotensin System Inhibitors Improve the Clinical Outcomes of COVID-19 Patients with Hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of Renin-Angiotensin System Inhibitors with Severity or Risk of Death in Patients with Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China","volume":"5","author":"Li","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s11845-022-03096-6","article-title":"The Effect of ACE Inhibitors and ARBs on Outcomes in Hospitalized Patients with COVID-19","volume":"192","author":"Najafi","year":"2023","journal-title":"Ir. J. Med. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000515232","article-title":"Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers","volume":"52","author":"Choksi","year":"2021","journal-title":"Am. J. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients with Hypertension Hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e00917","DOI":"10.1002\/prp2.917","article-title":"The Interacting Physiology of COVID-19 and the Renin-angiotensin-aldosterone System: Key Agents for Treatment","volume":"10","author":"Lumbers","year":"2022","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.medcli.2021.04.005","article-title":"Chronic Use of Renin\u2013Angiotensin\u2013Aldosterone Inhibitors in Hypertensive COVID-19 Patients: Results from a Spanish Registry and Meta-Analysis","volume":"158","author":"Aparisi","year":"2022","journal-title":"Med. Clin."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Silva-santos, Y., Pagni, R.L., Helena, T., Gamon, M., Santiago, M., de Azevedo, P., Bielavsky, M., de Souza, E.E., Wrenger, C., and Durigon, E.L. (2024). Lisinopril Increases Lung ACE2 Levels and SARS-CoV-2 Viral Load and Decreases in Fl Ammation but Not Disease Severity in Experimental COVID-19. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1414406"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Diaz, J.H. (2020). Hypothesis: Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers May Increase the Risk of Severe COVID-19. J. Travel. Med., 27.","DOI":"10.1093\/jtm\/taaa041"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are Patients with Hypertension and Diabetes Mellitus at Increased Risk for COVID-19 Infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"104927","DOI":"10.1016\/j.phrs.2020.104927","article-title":"ACEI\/ARB Use and Risk of Infection or Severity or Mortality of COVID-19: A Systematic Review and Meta-Analysis","volume":"158","author":"Zhang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41440-020-0433-1","article-title":"Antihypertensive Treatment with ACEI\/ARB of Patients with COVID-19 Complicated by Hypertension","volume":"43","author":"Li","year":"2020","journal-title":"Hypertens. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"147032031878262","DOI":"10.1177\/1470320318782623","article-title":"Inhibition of Renin-Angiotensin Axis Reduces the Risk of Thrombus Formation in the Left Atrial Appendage in Patients with Hypertension Complicated by Atrial Fibrillation","volume":"19","author":"Suo","year":"2018","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"147032032098132","DOI":"10.1177\/1470320320981321","article-title":"Effects of ACEI and ARB on COVID-19 Patients: A Meta-Analysis","volume":"21","author":"Xue","year":"2020","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/clc.23836","article-title":"Safety of ACEi and ARB in COVID-19 Management: A Retrospective Analysis","volume":"45","author":"Kumar","year":"2022","journal-title":"Clin. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/1573402118666220407093332","article-title":"ACEi\/ARB and Deaths of COVID-19 Patients","volume":"18","author":"Azad","year":"2022","journal-title":"Curr. Hypertens. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"de S\u00e1, K.S.G., Amaral, L.A., Rodrigues, T.S., Caetano, C.C.S., Becerra, A., Batah, S.S., Lopes, F.T., de Oliveira, I.M., Lopes, L.S., and Almeida, L. (2024). Pulmonary Inflammation and Viral Replication Define Distinct Clinical Outcomes in Fatal Cases of COVID-19. PLoS Pathog., 20.","DOI":"10.1371\/journal.ppat.1012222"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/j.1523-1755.2005.00675.x","article-title":"Effects of Renin-Angiotensin System Blockade on Renal Angiotensin-(1-7) Forming Enzymes and Receptors","volume":"68","author":"Ferrario","year":"2005","journal-title":"Kidney Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11886-020-01291-4","article-title":"Outcomes in Patients with COVID-19 Infection Taking ACEI\/ARB","volume":"22","author":"White","year":"2020","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40256-023-00605-5","article-title":"The Pivotal Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertension Management and Cardiovascular and Renal Protection: A Critical Appraisal and Comparison of International Guidelines","volume":"23","author":"Alcocer","year":"2023","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ehj.2004.06.003","article-title":"Expert Consensus Document on Angiotensin Converting Enzyme Inhibitors in Cardiovascular Disease The Task Force on ACE-Inhibitors of the European Society of Cardiology","volume":"25","author":"Swedberg","year":"2004","journal-title":"Eur. Heart J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1164\/rccm.202101-0142LE","article-title":"ACE2 Elevation in Severe COVID-19","volume":"203","author":"Eskandary","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13613-025-01433-3","article-title":"Renin\u2013Angiotensin\u2013Aldosterone System Activation in Plasma as Marker for Prognosis in Critically Ill Patients with COVID-19: A Prospective Exploratory Study","volume":"15","author":"Krenn","year":"2025","journal-title":"Ann. Intensive Care"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/HYPERTENSIONAHA.121.18295","article-title":"Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries","volume":"79","author":"Wang","year":"2022","journal-title":"Hypertension"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5492\/wjccm.v10.i4.132","article-title":"SARS-CoV-2 (COVID-19), Viral Load and Clinical Outcomes; Lessons Learned One Year into the Pandemic: A Systematic Review","volume":"10","author":"Shenoy","year":"2021","journal-title":"World J. Crit. Care Med."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Troyano, N., Gabriel-Medina, P., Weber, S., Klammer, M., Barqu\u00edn-DelPino, R., Castillo-Ribelles, L., Esteban, A., Hern\u00e1ndez-Gonz\u00e1lez, M., Ferrer-Costa, R., and Pumarola, T. (2022). Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2. Diagnostics, 12.","DOI":"10.3390\/diagnostics12040886"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1058120","DOI":"10.3389\/fmed.2022.1058120","article-title":"Sex Difference in Circulating Soluble Form of ACE2 Protein in Moderate and Severe COVID-19 and Healthy Controls","volume":"9","author":"Robertson","year":"2022","journal-title":"Front. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"L405","DOI":"10.1152\/ajplung.00372.2024","article-title":"The Circulating Renin-Angiotensin System and Mortality among Patients Hospitalized for COVID-19: A Mechanistic Substudy of the ACTIV-4 Host Tissue Trials","volume":"328","author":"Schaich","year":"2025","journal-title":"Am. J. Physiol. Cell Mol. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/14779072.2020.1826308","article-title":"Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers and Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis","volume":"18","author":"Lo","year":"2020","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.medcli.2020.06.013","article-title":"Risk of Severe COVID-19 in Hypertensive Patients Treated with Renin-Angiotensin-Aldosterone System Inhibitors","volume":"155","author":"Golpe","year":"2020","journal-title":"Med. Clin."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"100957","DOI":"10.1016\/j.eclinm.2021.100957","article-title":"A Multi-Center Phase II Randomized Clinical Trial of Losartan on Symptomatic Outpatients with COVID-19","volume":"37","author":"Puskarich","year":"2021","journal-title":"eClinicalMedicine"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.5471","article-title":"Angiotensin-converting Enzyme 2 (ACE2), SARS-CoV-2 and the Pathophysiology of Coronavirus Disease 2019 (COVID-19)","volume":"251","author":"Bourgonje","year":"2020","journal-title":"J. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"da Silva Santos, Y., Gamon, T.H.M., de Azevedo, M.S.P., Telezynski, B.L., de Souza, E.E., de Oliveira, D.B.L., Dombrowski, J.G., Rosa-Fernandes, L., Palmisano, G., and de Moura Carvalho, L.J. (2023). Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-HACE2 Transgenic Mice. Viruses, 15.","DOI":"10.3390\/v15040999"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Menachery, V.D., Gralinski, L.E., Baric, R.S., and Ferris, M.T. (2015). New Metrics for Evaluating Viral Respiratory Pathogenesis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0131451"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Pechous, R.D., Malaviarachchi, P.A., Xing, Z., Douglas, A., Crane, S.D., Theriot, H.M., Zhang, Z., Ghaffarieh, A., Huang, L., and Yu, Y.E. (2024). SARS-CoV-2 Infection Causes Heightened Disease Severity and Mortality in a Mouse Model of Down Syndrome. Biomedicines, 12.","DOI":"10.3390\/biomedicines12030543"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41421-022-00454-7","article-title":"Potential of Angiotensin II Receptor Blocker Telmisartan in Reducing Mortality among Hospitalized Patients with COVID-19 Compared with Recommended Drugs","volume":"8","author":"Liu","year":"2022","journal-title":"Cell Discov."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Rothlin, R.P., Pelorosso, F.G., Duarte, M., Nicolosi, L., Ignacio, F.C., Salgado, M.V., and Vetulli, H. (2023). Telmisartan and Losartan: The Marked Differences between Their Chemical and Pharmacological Properties May Explain the Difference in Therapeutic Efficacy in Hospitalized Patients with COVID-19. Pharmacol. Res. Perspect., 11.","DOI":"10.1002\/prp2.1083"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"100962","DOI":"10.1016\/j.eclinm.2021.100962","article-title":"Telmisartan for Treatment of COVID-19 Patients: An Open Multicenter Randomized Clinical Trial","volume":"37","author":"Duarte","year":"2021","journal-title":"eClinicalMedicine"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1021\/acs.molpharmaceut.2c00448","article-title":"Telmisartan Nanosuspension for Inhaled Therapy of COVID-19 Lung Disease and Other Respiratory Infections","volume":"20","author":"Chen","year":"2023","journal-title":"Mol. Pharm."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 Variants, Spike Mutations and Immune Escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-Acute COVID-19 Syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.2020.19719","article-title":"Long-Term Health Consequences of COVID-19","volume":"324","author":"Collins","year":"2020","journal-title":"JAMA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent Symptoms in Patients After Acute COVID-19","volume":"324","author":"Bernabei","year":"2020","journal-title":"JAMA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal Infection of K18-HACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus","volume":"81","author":"McCray","year":"2007","journal-title":"J. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.4269\/ajtmh.20-0762","article-title":"Evaluation of K18-HACE2 Mice as a Model of SARS-CoV-2 Infection","volume":"103","author":"Moreau","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Yinda, C.K., Port, J.R., Bushmaker, T., Owusu, I.O., Purushotham, J.N., Avanzato, V.A., Fischer, R.J., Schulz, J.E., Holbrook, M.G., and Hebner, M.J. (2021). K18-HACE2 Mice Develop Respiratory Disease Resembling Severe COVID-19. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009195"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Araujo, D.B., Machado, R.R.G., Amgarten, D.E., Malta, F.d.M., de Araujo, G.G., Monteiro, C.O., Candido, E.D., Soares, C.P., de Menezes, F.G., and Pires, A.C.C. (2020). SARS-CoV-2 Isolation from the First Reported Patients in Brazil and Establishment of a Coordinated Task Network. Mem. Inst. Oswaldo Cruz, 115.","DOI":"10.1590\/0074-02760200342"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.etp.2006.02.014","article-title":"Further Exploration of the Penh Parameter","volume":"57","author":"Lomask","year":"2006","journal-title":"Exp. Toxicol. Pathol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMct074213","article-title":"Low-Tidal-Volume Ventilation in the Acute Respiratory Distress Syndrome","volume":"357","author":"Malhotra","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_73","unstructured":"Hallett, S., Toro, F., and Ashurst, J.V. (2021). Physiology, Tidal Volume, StatPearls."},{"key":"ref_74","unstructured":"(2021, August 15). UNIFESP Guide to Implementation of Humanitarian End Point. Available online: https:\/\/ceua.unifesp.br\/images\/documentos\/CEUA\/Guia_EndPoint_CEUA_UNIFESP_2020.pdf."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nmeth.1455","article-title":"Coding of Facial Expressions of Pain in the Laboratory Mouse","volume":"7","author":"Langford","year":"2010","journal-title":"Nat. Methods"},{"key":"ref_76","first-page":"3564","article-title":"Whole Animal Perfusion Fixation for Rodents","volume":"65","author":"Gage","year":"2012","journal-title":"J. Vis. Exp."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2000045","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 Novel Coronavirus (2019-NCoV) by Real-Time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Eurosurveillance"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/16\/7663\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:26:07Z","timestamp":1760034367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/16\/7663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":77,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26167663"],"URL":"https:\/\/doi.org\/10.3390\/ijms26167663","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}